Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Somatic cell nuclear transfer allows trans-acting factors present in the mammalian oocyte to reprogram somatic cell nuclei to an undifferentiated state. We show that four factors ( OCT4, SOX2, NANOG , and LIN28 ) are sufficient to reprogram human somatic cells to pluripotent stem cells that exhibit the essential characteristics of embryonic stem (ES) cells. These induced pluripotent human stem cells have normal karyotypes, express telomerase activity, express cell surface markers and genes that characterize human ES cells, and maintain the developmental potential to differentiate into advanced derivatives of all three primary germ layers. Such induced pluripotent human cell lines should be useful in the production of new disease models and in drug development, as well as for applications in transplantation medicine, once technical limitations (for example, mutation through viral integration) are eliminated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Retro/lentiviruses have enabled genetic approaches in cultured primary cells to ectopically express genes of interest (1–6).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Viral screens using focused overexpression libraries can identify putative reprogramming factors, for example, by identifying a defined set of transcription factors that are selectively required to induce pluripotent stem cells (2–4,7) or trans-differentiate from mature somatic cell into another mature somatic cell (1,8–11).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Despite the power of viral technologies, pooled screens for cell reprogramming have generally adopted a one-by-one elimination approach or testing for exhaustive combinations and interrogating phenotypes in cell culture from transgenic mice (1,3,10) and/or aberrantly cloned cell lines (12).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Successful transformation of human somatic cells into iPSCs was first carried out in 2007 using a lentiviral system [95].”
From Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through (2022) · cites this paper as [95]
In the citing paper
“It has been shown that NANOG and LIN28 in combination with SOX2 and OCT4 can reprogram human somatic cells into iPS cells 30 by increasing reprogramming efficiency by 76-fold 60 .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [30]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Self-citationThe ENCODE Project Consortium (2007) · Nature · doi:10.1038/nature05874 · Cited by 5,223
Viable offspring derived from fetal and adult mammalian cells
Wilmut, I., Schnieke, A. E., McWhir, J., Kind, A. J., & Campbell, K. H. S. (1997) · Nature · doi:10.1038/385810a0 · Cited by 4,969
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells
Meissner, A., Wernig, M., & Jaenisch, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1335 · Cited by 763
Homologous recombination in human embryonic stem cells
Zwaka, T. P., & Thomson, J. A. (2003) · Nature Biotechnology · doi:10.1038/nbt788 · Cited by 666
Self-citationVodyanik, M. A., Bork, J. A., Thomson, J. A., & Slukvin, I. I. (2005) · Blood · doi:10.1182/blood-2004-04-1649 · Cited by 619
Self-citation
Cited by
Items 801–900 of 1,133
Roles of Integrins in Human Induced Pluripotent Stem Cell Growth on Matrigel and Vitronectin
Rowland, T. J., Miller, L. M., Blaschke, A. J., Doss, E. L., Bonham, A. J., Hikita, S. T., Johnson, L. V., & Clegg, D. O. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0328 · Cited by 181
“First, microarray data generated by Yu et al. [1] were analyzed to compare iPSC and hESC integrin mRNA expression (Supplementary Fig.”
InfluentialDNA Damage Responses in Human Induced Pluripotent Stem Cells and Embryonic Stem Cells
Momcilovic, O., Knobloch, L., Fornsaglio, J., Varum, S., Easley, C., & Schatten, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013410 · Cited by 173
“Two cocktails of transcription factors were successfully used: OCT4, SOX2, KLF4 and c-MYC [1,2], or OCT4, NANOG, SOX2 and LIN28 [3].”
MethodKo, J.-Y., Kim, K.-I., Park, S., & Im, G.-I. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.009 · Cited by 177
Novak, A., Barad, L., Zeevi‐Levin, N., Shick, R., Shtrichman, R., Lorber, A., Itskovitz‐Eldor, J., & Binah, O. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01476.x · Cited by 177
“Indeed, since the seminal breakthrough of generating iPSCs [36, 37], several patient-specific iPSCs lines were developed for a variety of diseases, including neurodegenerative diseases and metabolic disorders [38, 39].”
BackgroundPresent and future challenges of induced pluripotent stem cells
Ohnuki, M., & Takahashi, K. (2015) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2014.0367 · Cited by 174
Xu, J., Watts, J. A., Pope, S. D., Gadue, P., Kamps, M., Plath, K., Zaret, K. S., & Smale, S. T. (2009) · Genes & Development · doi:10.1101/gad.1861209 · Cited by 176
“Recent studies have demonstrated that differentiated cells can be reprogrammed to iPS cells by expression of a cocktail of defined transcription factors (Takahashi and Yamanaka 2006; Maherali et al. 2007; Takahashi et al. 2007; Wernig et al. 2007; Yu et al. 2007; Park et al. 2008).”
BackgroundHuman pluripotent reprogramming with CRISPR activators
Weltner, J., Balboa, D., Katayama, S., Bespalov, M., Krjutškov, K., Jouhilahti, E.-M., Trokovic, R., Kere, J., & Otonkoski, T. (2018) · Nature Communications · doi:10.1038/s41467-018-05067-x · Cited by 181
Energy metabolism and energy-sensing pathways in mammalian embryonic and adult stem cell fate
Rafalski, V. A., Mancini, E., & Brunet, A. (2012) · Journal of Cell Science · doi:10.1242/jcs.114827 · Cited by 182
“This cellular reprogramming was subsequently demonstrated in human cells (Takahashi et al., 2007; Yu et al., 2007).”
BackgroundHotta, A., & Ellis, J. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21912 · Cited by 173
“Consistent with this observation, lentiviral vectors have been used for successful induction of mouse and human iPS cells, although it was not shown that they were silenced [Blelloch et al., 2007; Yu et al., 2007].”
BackgroundLin28/let-7 axis regulates aerobic glycolysis and cancer progression via PDK1
Ma, X., Li, C., Sun, L., Huang, D., Li, T., He, X., Wu, G., Yang, Z., Zhong, X., Song, L., et al. (2014) · Nature Communications · doi:10.1038/ncomms6212 · Cited by 179
Glial Progenitor Cell–Based Treatment and Modeling of Neurological Disease
Goldman, S. A., Nedergaard, M., & Windrem, M. S. (2012) · Science · doi:10.1126/science.1218071 · Cited by 181
Zhang, S., Chen, S., Li, W., Guo, X., Zhao, P., Xu, J., Chen, Y., Pan, Q., Liu, X., Zychlinski, D., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr223 · Cited by 173
Extracellular Vesicles: Satellites of Information Transfer in Cancer and Stem Cell Biology
Desrochers, L. M., Antonyak, M. A., & Cerione, R. A. (2016) · Developmental Cell · doi:10.1016/j.devcel.2016.04.019 · Cited by 178
“However, what makes these findings particularly intriguing is that ectopically expressing several of these stemnesspromoting proteins in fully differentiated cell types (e.g., fibroblasts) can reprogram the cells to dedifferentiate into a stem cell-like state (Yu et al., 2007).”
BackgroundModeling Neurological Diseases With Human Brain Organoids
Wang, H. (2018) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2018.00015 · Cited by 173
“The iPSCs derived from patients are now widely used in disease modeling (Takahashi and Yamanaka, 2006; Yu et al., 2007; Wang and Doering, 2012; Shi et al., 2017).”
MethodMechanism-based facilitated maturation of human pluripotent stem cell-derived cardiomyocytes
Lieu, D. K., Fu, J.-D., Chiamvimonvat, N., Tung, K. C., McNerney, G. P., Huser, T., Keller, G., Kong, C.-W., & Li, R. A. (2013) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.111.973420 · Cited by 179
“James Thomson (Wisconsin, Madison), were also maintained as described.(11) IPSC-CMs were derived via EB formation following the H1 hESC differentiation protocol.”
MethodRegenerative medicine strategies
Atala, A. (2012) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2011.10.013 · Cited by 173
Disease characterization using LQTS-specific induced pluripotent stem cells
Egashira, T., Yuasa, S., Suzuki, T., Aizawa, Y., Yamakawa, H., Matsuhashi, T., Ohno, Y., Tohyama, S., Okata, S., Seki, T., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs206 · Cited by 178
“Human-induced pluripotent stem cells (hiPSCs) have become a promising tool for analysing human genetic diseases.(8,9) Many studies have already shown that apparent cellular phenotypes of familial genetic disorders are recapitulated by disease-specific iPSC-derived cells in vitro.”
BackgroundYoshida, S., Miyagawa, S., Fukushima, S., Kawamura, T., Kashiyama, N., Ohashi, F., Toyofuku, T., Toda, K., & Sawa, Y. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.08.012 · Cited by 178
LIN28: roles and regulation in development and beyond
Tsialikas, J., & Romer-Seibert, J. (2015) · Development · doi:10.1242/dev.117580 · Cited by 176
“In combination with NANOG, OCT4 (POU5F1) and SOX2, it can reprogram somatic cells to pluripotent stem cells (Yu et al., 2007).”
BackgroundInfluentialiPS cells: A source of cardiac regeneration
Yoshida, Y., & Yamanaka, S. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.026 · Cited by 171
“Human iPS cells were established in 2007, by the transduction of either the same set of transcription factors (c-Myc, Oct3/4, SOX2, Klf4) or another set of transcription factors (Oct3/4, SOX2, Nanog, Lin28) into human fibroblasts [19, 20].”
BackgroundGeneration of Induced Pluripotent Stem Cells in Rabbits
Honda, A., Hirose, M., Hatori, M., Matoba, S., Miyoshi, H., Inoue, K., & Ogura, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.150540 · Cited by 173
Cellular cardiomyoplasty and cardiac tissue engineering for myocardial therapy☆
Wang, F., & Guan, J. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.001 · Cited by 174
Generation of Red Blood Cells from Human Induced Pluripotent Stem Cells
Dias, J., Gumenyuk, M., Kang, H., Vodyanik, M., Yu, J., Thomson, J. A., & Slukvin, I. I. (2011) · Stem Cells and Development · doi:10.1089/scd.2011.0078 · Cited by 175
“Transgenic iPSCs (SK46)-M4-10 (TiPSC1) and Foreskin-1 (TiPSC2) (passages 9– 35) were obtained by reprogramming human adult and fetal fibroblasts with POU5F1, SOX2, and NANOG lentiviral vectors [11,17].”
Self-citationWu, H., Lee, J., Vincent, L. G., Wang, Q., Gu, M., Lan, F., Churko, J. M., Sallam, K. I., Matsa, E., Sharma, A., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.04.020 · Cited by 177
“Ever since the discovery of the four key reprogramming factors by Takahashi and Yamanaka (2006), significant strides have been made in deriving cardiomyocytes from human originated stem cells (Burridge et al., 2012; Takahashi et al., 2007; Yu et al., 2007).”
BackgroundNeural stem cell‐based treatment for neurodegenerative diseases
Kim, S. U., Lee, H. J., & Kim, Y. B. (2013) · Neuropathology · doi:10.1111/neup.12020 · Cited by 169
“fibroblasts by introduction of embryogenesis-related genes.(3,4) A recent study has indicated that patients’ own fibroblasts could directly be converted into neurons by combinatorial expression of three neural lineage-specific transcription factors, Ascl1, Brn2 and Myt1l.”
BackgroundMadison, J. M., Zhou, F., Nigam, A., Hussain, A., Barker, D. D., Nehme, R., van der Ven, K., Hsu, J., Wolf, P., Fleishman, M., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.7 · Cited by 179
“17–19).”
Liao, J., Wu, Z., Wang, Y., Cheng, L., Cui, C., Gao, Y., Chen, T., Rao, L., Chen, S., Jia, N., et al. (2008) · Cell Research · doi:10.1038/cr.2008.51 · Cited by 175
Pirozzi, G., Tirino, V., Camerlingo, R., Franco, R., La Rocca, A., Liguori, E., Martucci, N., Paino, F., Normanno, N., & Rocco, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021548 · Cited by 172
“Most importantly, it is well known that the co-expression of Sox-2, Nanog and Oct4 in human or mouse somatic cells can reprogram these cells into pluripotent embryonic stem-like cells [40,41].”
BackgroundHydrogels for cardiac tissue engineering
Camci-Unal, G., Annabi, N., Dokmeci, M. R., Liao, R., & Khademhosseini, A. (2014) · NPG Asia Materials · doi:10.1038/am.2014.19 · Cited by 170
Yahata, N., Asai, M., Kitaoka, S., Takahashi, K., Asaka, I., Hioki, H., Kaneko, T., Maruyama, K., Saido, T. C., Nakahata, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025788 · Cited by 174
“Induced pluripotent stem (iPS) cells reprogrammed from somatic cells [5,6] provide an opportunity to easily generate and use patient-specific differentiated cells.”
Ruiz, S., Diep, D., Gore, A., Panopoulos, A. D., Montserrat, N., Plongthongkum, N., Kumar, S., Fung, H.-L., Giorgetti, A., Bilic, J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202352109 · Cited by 170
Vallier, L., Touboul, T., Brown, S., Cho, C., Bilican, B., Alexander, M., Cedervall, J., Chandran, S., Ährlund-Richter, L., Weber, A., et al. (2009) · Stem Cells · doi:10.1002/stem.199 · Cited by 174
Cold shock proteins: from cellular mechanisms to pathophysiology and disease
Lindquist, J. A., & Mertens, P. R. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0274-6 · Cited by 173
Axon Regeneration in the Mammalian Optic Nerve
Williams, P. R., Benowitz, L. I., Goldberg, J. L., & He, Z. (2020) · Annual Review of Vision Science · doi:10.1146/annurev-vision-022720-094953 · Cited by 176
Doss, M. X., Di Diego, J. M., Goodrow, R. J., Wu, Y., Cordeiro, J. M., Nesterenko, V. V., Barajas-Martínez, H., Hu, D., Urrutia, J., Desai, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040288 · Cited by 169
“The human iPS cell line IMR-90-C4 (WiCell, Madison, WI, USA), reprogrammed with Oct4, Sox2, Lin28 and Nanog as described previously, [22] was maintained in serum-free, feederfree conditions with mTeSR1 media (Stem Cell Technologies, Vancouver, Canada) on BD Matrigel (BD Biosciences, CA) coated dishes for routine expan…”
MethodThe biology of head and neck cancer stem cells
Zhang, Z., Filho, M. S., & Nör, J. E. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2011.10.004 · Cited by 172
Generation of Functional Mesenchymal Stem Cells from Different Induced Pluripotent Stem Cell Lines
Hynes, K., Menicanin, D., Mrozik, K., Gronthos, S., & Bartold, P. M. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0111 · Cited by 171
“The discovery that induced pluripotent stem cells (iPSC) can be generated from adult somatic cells using reprogramming techniques [21,22] represents a promising alternative for obtaining larger populations of adult stem cells for use in cell therapies and regenerative medicine.”
Roles of Krüppel-like factor 4 in normal homeostasis, cancer and stem cells
Evans, P. M., & Liu, C. (2008) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2008.00439.x · Cited by 169
Yoshida, Y., & Yamanaka, S. (2010) · Circulation · doi:10.1161/circulationaha.109.881433 · Cited by 172
Yong, X., Tang, B., Xiao, Y.-F., Xie, R., Qin, Y., Luo, G., Hu, C.-J., Dong, H., & Yang, S.-M. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.02.032 · Cited by 174
Advances of injectable hydrogel-based scaffolds for cartilage regeneration
Li, J., Chen, G., Xu, X., Abdou, P., Jiang, Q., Shi, D., & Gu, Z. (2019) · Regenerative Biomaterials · doi:10.1093/rb/rbz022 · Cited by 174
“Recently, iPSCs have attracted significant attention because they exhibit pluripotency that is quite similar to ESCs in terms of multiple differentiation routes, thus resulting in increasingly widespread applications in regenerative medicine, which can be obtained from somatic cells including fibroblasts [129, 149].”
BackgroundVital Pulp Therapy—Current Progress of Dental Pulp Regeneration and Revascularization
Zhang, W., & Yelick, P. C. (2010) · International Journal of Dentistry · doi:10.1155/2010/856087 · Cited by 166
“Perhaps the most promising solution might be induced pluripotent stem cells (iPSCs), cells that have been artificially derived through stem cell gene transfer into an adult somatic cell [90, 91].”
BackgroundWang, B., Jha, J. C., Hagiwara, S., McClelland, A. D., Jandeleit-Dahm, K., Thomas, M. C., Cooper, M. E., & Kantharidis, P. (2014) · Kidney International · doi:10.1038/ki.2013.372 · Cited by 175
Claassen, D. A., Desler, M. M., & Rizzino, A. (2009) · Molecular Reproduction and Development · doi:10.1002/mrd.21021 · Cited by 162
“In the past few years, several groups have reported the creation of iPS cells from human fibroblasts, which appear by many criteria to be remarkably similar to hES cells (Takahashi et al., 2007; Yu et al., 2007; Park et al., 2008; Lowry et al., 2008; Liao et al., 2008; Nakagawa et al., 2008).”
BackgroundMethodTargeting cancer stem cells: emerging role of Nanog transcription factor
Wu, C.-W. (., Wang, M.-L., & Chiou, S.-H. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s38114 · Cited by 169
“therefore increase the survival rate of early reprogrammed cells.(88) The suppressive effect of p53 on reprogramming and cancer-stemness could partially count on its negative regulation of Nanog.”
Dowey, S. N., Huang, X., Chou, B.-K., Ye, Z., & Cheng, L. (2012) · Nature Protocols · doi:10.1038/nprot.2012.121 · Cited by 174
Zhong, X., Li, N., Liang, S., Huang, Q., Coukos, G., & Zhang, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.169607 · Cited by 169
ESCs Require PRC2 to Direct the Successful Reprogramming of Differentiated Cells toward Pluripotency
Pereira, C. F., Piccolo, F. M., Tsubouchi, T., Sauer, S., Ryan, N. K., Bruno, L., Landeira, D., Santos, J., Banito, A., Gil, J., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.013 · Cited by 168
“Compromised Reprogramming by PRC2 Mutant ESCs Is Not due to a Deficit in Known Reprogramming Factors To examine whether PRC2-deficient ESCs fail to efficiently reprogram human B cells because they misregulate endogenous factors that have previously shown to be critical for iPS-based reprogramming (Takahashi et al., 20…”
BackgroundMethodIonizing Radiation Induces Stemness in Cancer Cells
Ghisolfi, L., Keates, A. C., Hu, X., Lee, D.-K., & Li, C. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043628 · Cited by 165
“Along with c-Myc, Klf4 and NANOG, Sox2 and Oct3/4 transcription factors are considered key genes for the production of murine and human induced pluripotent stem cells [57,58].”
BackgroundVascular tissue engineering: from in vitro to in situ
Li, S., Sengupta, D., & Chien, S. (2014) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1246 · Cited by 164
Eukaryotic cold shock domain proteins: highly versatile regulators of gene expression
Mihailovich, M., Militti, C., Gabaldón, T., & Gebauer, F. (2010) · BioEssays · doi:10.1002/bies.200900122 · Cited by 165
“Indeed, Lin-28 is a marker of cell ‘‘stemness’’ and cooperates with three other factors to reprogram human somatic cells into pluripotent stem cells.((30,31))”
BackgroundNeural Regeneration and Cell Replacement: A View from the Eye
Lamba, D., Karl, M., & Reh, T. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.05.002 · Cited by 167
Adult cell therapy for brain neuronal damages and the role of tissue engineering
Delcroix, G. J.-R., Schiller, P. C., Benoit, J.-P., & Montero-Menei, C. N. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.084 · Cited by 167
“An emerging potential source of adult stem cells, which was first described in 2007 by 2 different teams, are the iPS cells generated from terminally differentiated somatic cells via nuclear reprogramming [197,198].”
Small RNAs in early mammalian development: from gametes to gastrulation
Suh, N., & Blelloch, R. (2011) · Development · doi:10.1242/dev.056234 · Cited by 166
“Furthermore, inhibition of Let-7 function, either through overexpression of Lin28, which blocks Let-7 biogenesis, or through antagomirs, which directly target mature Let-7, is able to promote iPS cell production (Melton et al., 2010; Yu et al., 2007).”
BackgroundSenju, S., Haruta, M., Matsumura, K., Matsunaga, Y., Fukushima, S., Ikeda, T., Takamatsu, K., Irie, A., & Nishimura, Y. (2011) · Gene Therapy · doi:10.1038/gt.2011.22 · Cited by 171
Lalit, P. A., Salick, M. R., Nelson, D. O., Squirrell, J. M., Shafer, C. M., Patel, N. G., Saeed, I., Schmuck, E. G., Markandeya, Y. S., Wong, R., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2015.12.001 · Cited by 174
“more challenging to reprogram compared with embryonic or neonatal cells (Takahashi and Yamanaka, 2006; Yu et al., 2007).”
BackgroundSelf-citationMultiorgan Microphysiological Systems for Drug Development: Strategies, Advances, and Challenges
Wang, Y. I., Carmona, C., Hickman, J. J., & Shuler, M. L. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701000 · Cited by 167
Differential roles of Sall4 isoforms in embryonic stem cell pluripotency
Rao, S., Zhen, S., Roumiantsev, S., McDonald, L. T., Yuan, G.-C., & Orkin, S. H. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00419-10 · Cited by 173
“Various combinations of pluripotency factors (Oct4, Sox2, and Nanog), plus accessory components (c-Myc and Lin28), are sufficient to induce pluripotency in somatic cells (iPS) (39, 48).”
BackgroundHuman stem cells and drug screening: opportunities and challenges
Ebert, A. D., & Svendsen, C. N. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3000 · Cited by 172
“A year later, three studies used similar techniques to reprogramme human fibroblast”
MethodThe role of microRNAs in the regulation of cancer stem cells
Takahashi, R.-U., Miyazaki, H., & Ochiya, T. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2013.00295 · Cited by 118
Rizzino, A. (2009) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.12 · Cited by 166
Yi, F., Pereira, L., & Merrill, B. J. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0229 · Cited by 164
Olmer, R., Haase, A., Merkert, S., Cui, W., Paleček, J., Ran, C., Kirschning, A., Scheper, T., Glage, S., Miller, K., et al. (2010) · Stem Cell Research · doi:10.1016/j.scr.2010.03.005 · Cited by 169
“The recently demonstrated reprogramming of terminally differentiated human cells into "human induced pluripotent (hiPS) cells" (Takahashi et al., 2007; Yu et al., 2007) was a major stimulus in stem cell research and eliminated two major obstacles to the clinical application of human embryonic stem (hES) cells – the et…”
BackgroundGraphene‐Based Materials in Regenerative Medicine
Ding, X., Liu, H., & Fan, Y. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500203 · Cited by 169
PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype
Duan, S., Yuan, G., Liu, X., Ren, R., Li, J., Zhang, W., Wu, J., Xu, X., Fu, L., Li, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms10068 · Cited by 167
Stem Cells and Cell Therapies in Lung Biology and Lung Diseases
Weiss, D. J., Bertoncello, I., Borok, Z., Kim, C., Panoskaltsis-Mortari, A., Reynolds, S., Rojas, M., Stripp, B., Warburton, D., & Prockop, D. J. (2011) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201012-071dw · Cited by 171
A Not‐So‐New Eugenics: Harris and Savulescu on Human Enhancement
SPARROW, R. (2011) · Hastings Center Report · doi:10.1002/j.1552-146x.2011.tb00098.x · Cited by 158
“3 If the technology to create germ cells from somatic cells via Induced Pluripotent Stem-cells is realised (Aldhous 2008; Yu et al. 2007) then this will further extend the potential of PGD by greatly increasing the number of embryos a couple can create.”
BackgroundHynes, S. R., & Lavik, E. B. (2010) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-009-1263-7 · Cited by 169
“Progenitor and stem cells ESCs have demonstrated robust integration into host retina and the ability to rescue photoreceptors and visual acuity in rodent models [87].”
Choi, K.-D., Vodyanik, M., & Slukvin, I. I. (2011) · Nature Protocols · doi:10.1038/nprot.2010.184 · Cited by 167
“A year later, induced pluripotent stem cells (iPSCs) were obtained from human somatic cell”
BackgroundSelf-citationUnraveling Epigenetic Regulation in Embryonic Stem Cells
Bibikova, M., Laurent, L. C., Ren, B., Loring, J. F., & Fan, J.-B. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.01.005 · Cited by 170
Hursting, S. D., & Dunlap, S. M. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06737.x · Cited by 166
Phage‐Enabled Nanomedicine: From Probes to Therapeutics in Precision Medicine
Sunderland, K. S., Yang, M., & Mao, C. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201606181 · Cited by 171
Missing pieces in understanding the intracellular trafficking of polycation/DNA complexes
Won, Y.-Y., Sharma, R., & Konieczny, S. F. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.06.031 · Cited by 170
Gourraud, P.-A., Gilson, L., Girard, M., & Peschanski, M. (2012) · Stem Cells · doi:10.1002/stem.772 · Cited by 163
Ware, C. B., Wang, L., Mecham, B. H., Shen, L., Nelson, A. M., Bar, M., Lamba, D. A., Dauphin, D. S., Buckingham, B., Askari, B., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.03.001 · Cited by 166
“…explain the inefficiency inherent in generating new ES-like cells—induced pluripotent stem (iPS) cells (Takahashi and Yamanaka, 2006; Nakagawa et al., 2007; Park et al., 2007; Takahashi et al., 2007; Yu et al., 2007) and epiblast stem cells (EpiSCs) (Brons et al., 2007; Tesar et al., 2007).”
Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells
Li, C., Zhou, J., Shi, G., Ma, Y., Yang, Y., Gu, J., Yu, H., Jin, S., Wei, Z., Chen, F., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp386 · Cited by 170
“Since the first report of generation of iPS cells in 2006 (1), a great deal of effort has been made to address the low efficiency and the safety issues associated with initial generation of mouse and human iPS cells obtained through viral delivery of four transcription factors (Oct4, Sox2, Klf4 and c-Myc) (2,3).”
BackgroundLIN28/LIN28B: An emerging oncogenic driver in cancer stem cells
Zhou, J., Ng, S.-B., & Chng, W.-J. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.02.006 · Cited by 163
Gingival Fibroblasts as a Promising Source of Induced Pluripotent Stem Cells
Egusa, H., Okita, K., Kayashima, H., Yu, G., Fukuyasu, S., Saeki, M., Matsumoto, T., Yamanaka, S., & Yatani, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012743 · Cited by 167
Bernardo, A. S., Hay, C. W., & Docherty, K. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.07.006 · Cited by 164
Development of human embryonic stem cell therapies for age-related macular degeneration
Carr, A.-J. F., Smart, M. J. K., Ramsden, C. M., Powner, M. B., da Cruz, L., & Coffey, P. J. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.03.006 · Cited by 167
Lin, S.-L., Chang, D. C., Ying, S.-Y., Leu, D., & Wu, D. T. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2746 · Cited by 168
Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells
Mizuno, Y., Chang, H., Umeda, K., Niwa, A., Iwasa, T., Awaya, T., Fukada, S., Yamamoto, H., Yamanaka, S., Nakahata, T., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-137174 · Cited by 162
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells
Kim, Y., Kang, K., Lee, S. B., Seo, D., Yoon, S., Kim, S. J., Jang, K., Jung, Y. K., Lee, K. G., Factor, V. M., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.007 · Cited by 167
Ji, H., Wu, G., Zhan, X., Nolan, A., Koh, C., De Marzo, A., Doan, H. M., Fan, J., Cheadle, C., Fallahi, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026057 · Cited by 164
“It is intriguing to note that the three factors, Sox2, Oct4, and Klf4, can be complemented by either MYC or LIN28 to induce more efficiently pluripotency in fibroblasts [54,55].”
BackgroundRegeneration Next: Toward Heart Stem Cell Therapeutics
Hansson, E. M., Lindsay, M. E., & Chien, K. R. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.09.004 · Cited by 166
Atg5-independent autophagy regulates mitochondrial clearance and is essential for iPSC reprogramming
Ma, T., Li, J., Xu, Y., Yu, C., Xu, T., Wang, H., Liu, K., Cao, N., Nie, B.-M., Zhu, S.-Y., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3256 · Cited by 167
Role of Hox genes in stem cell differentiation
Seifert, A. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i3.583 · Cited by 165
Engineering Human Stem Cell Lines with Inducible Gene Knockout using CRISPR/Cas9
Chen, Y., Cao, J., Xiong, M., Petersen, A. J., Dong, Y., Tao, Y., Huang, C. T.-L., Du, Z., & Zhang, S.-C. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.06.001 · Cited by 157
“Human pluripotent stem cells (hPSCs), including embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), are useful tools for elucidating regulatory processes during early development and disease pathogenesis under the human genetic background (Takahashi et al., 2007; Thomson et al., 1998; Yu et al., 20…”
Hayashi, R., Ishikawa, Y., Ito, M., Kageyama, T., Takashiba, K., Fujioka, T., Tsujikawa, M., Miyoshi, H., Yamato, M., Nakamura, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045435 · Cited by 159
“Like embryonic stem cells, induced pluripotent stem (iPS) cells are capable of differentiating into all of the various cell lineages of an organism, and are established from somatic cells by introducing transcription factors such as Oct3/4, Sox2, and Klf4 [1–3].”
BackgroundMicro RNA‐145: a potent tumour suppressor that regulates multiple cellular pathways
Cui, S., Wang, R., & Chen, L. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12358 · Cited by 158
Rajala, K., Lindroos, B., Hussein, S. M., Lappalainen, R. S., Pekkanen-Mattila, M., Inzunza, J., Rozell, B., Miettinen, S., Narkilahti, S., Kerkelä, E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010246 · Cited by 166
“linked to pluripotency to yield induced pluripotent stem cells (iPSC) [4,5].”
BackgroundDerivation of Induced Pluripotent Stem Cells from Human Peripheral Blood T Lymphocytes
Brown, M. E., Rondon, E., Rajesh, D., Mack, A., Lewis, R., Feng, X., Zitur, L. J., Learish, R. D., & Nuwaysir, E. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011373 · Cited by 164
“Activated T-cell enriched populations containing 16106 cells were subjected to two rounds (at day 0 and 1) of retroviral transduction with four separate vectors, each encoding one of the reprogramming factors (SOX2, OCT4, c-Myc, or KLF4) linked to a fluorescent marker gene.”
BackgroundMethodInfluentialRodriguez, M. L., Graham, B. T., Pabon, L. M., Han, S. J., Murry, C. E., & Sniadecki, N. J. (2014) · Journal of Biomechanical Engineering · doi:10.1115/1.4027145 · Cited by 162
“Human iPSCs derived from the IMR-90 lung fibroblast cell line (Thomson and Wisconsin-Madison) [51] were propagated under feeder-free conditions.”
MethodQuantitative Comparison of Constitutive Promoters in Human ES cells
Norrman, K., Fischer, Y., Bonnamy, B., Wolfhagen Sand, F., Ravassard, P., & Semb, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012413 · Cited by 162
“To reprogram somatic cells into induced pluripotent cells (iPSCs), the constitutively active elongation factor-1a (EF1a) promoter was used to overexpress the four transcription factors SOX2, OCT3/4, KLF4 and c-MYC [3–5].”
Wang, G., Guo, X., Hong, W., Liu, Q., Wei, T., Lu, C., Gao, L., Ye, D., Zhou, Y., Chen, J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212769110 · Cited by 149
Anguera, M. C., Sadreyev, R., Zhang, Z., Szanto, A., Payer, B., Sheridan, S. D., Kwok, S., Haggarty, S. J., Sur, M., Alvarez, J., et al. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.03.008 · Cited by 168
“This caught our attention, given that loss of Xist has been shown to result in partial X reactivation in murine cells (Csankovszki et al., 2001; Zhang et al., 2007) and overexpression of X genes has been correlated with cancer (Richardson et al., 2006; Pageau et al., 2007).”
Lu, S.-J., Li, F., Yin, H., Feng, Q., Kimbrel, E. A., Hahm, E., Thon, J. N., Wang, W., Italiano, J. E., Cho, J., et al. (2011) · Cell Research · doi:10.1038/cr.2011.8 · Cited by 163
“Importantly, by using induced pluripotent stem cells [34-37], it may be possible to adapt these differentiation protocols to produce patient-specific platelets for transfusion-dependent patients who develop platelet alloimmunity.”
Yücel, G., Zhao, Z., El-Battrawy, I., Lan, H., Lang, S., Li, X., Buljubasic, F., Zimmermann, W.-H., Cyganek, L., Utikal, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03147-4 · Cited by 161
Lin28 sustains early renal progenitors and induces Wilms tumor
Urbach, A., Yermalovich, A., Zhang, J., Spina, C. S., Zhu, H., Perez-Atayde, A. R., Shukrun, R., Charlton, J., Sebire, N., Mifsud, W., et al. (2014) · Genes & Development · doi:10.1101/gad.237149.113 · Cited by 164
“Lin28 also promotes reprogramming of somatic cells into induced pluripotent cells (Yu et al. 2007).”
BackgroundiPSC-derived forebrain neurons from FXS individuals show defects in initial neurite outgrowth
Doers, M. E., Musser, M. T., Nichol, R., Berndt, E. R., Baker, M., Gomez, T. M., Zhang, S.-C., Abbeduto, L., & Bhattacharyya, A. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0030 · Cited by 165
“iPSC technology has enabled the generation of pluripotent stem cell lines from patients with disease-causing mutations to model diseases [30,31,50].”
Background
Metadata
- Authors
- Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., Slukvin, I. I., & Thomson, J. A.
- Affiliations
- WiCell (US)
- Genome Center of Wisconsin, Madison, WI 53706–1580, USA.
- Venue
- Science
- Published
- 2007-12-21
- Volume
- 318
- Issue
- 5858
- Pages
- 1917-1920
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2142046859
- Cited by
- 10,310
- References
- 14
- Citations by year
- 2026: 167 · 2025: 219 · 2024: 285 · 2023: 322 · 2022: 332 · 2021: 506 · 2020: 441 · 2019: 443 · 2018: 452 · 2017: 515 · 2016: 580 · 2015: 652 · 2014: 692 · 2013: 816 · 2012: 940
- FWCI
- 271.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (P20GM069981)
- National Center for Research Resources (P51RR000167)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- induced pluripotent stem cells, somatic cell nuclear transfer, reprogramming factors, Oct4, SOX2, Nanog, Lin28, pluripotency, telomerase activity, germ layer differentiation, karyotype, disease models, drug development, transplantation medicine
- MeSH terms
- Nanog Homeobox Protein, Animals, Cell Differentiation, Cell Line, DNA-Binding Proteins, Fetus, Fibroblasts, Humans, Infant, Newborn, Karyotyping, Teratoma, Transcription Factors, Transduction, Genetic, Mice, SCID, RNA-Binding Proteins, Homeodomain Proteins, Transgenes, Oligonucleotide Array Sequence Analysis, HMGB Proteins, Stem Cell Transplantation, Pluripotent Stem Cells, Cell Shape, Cell Proliferation, Octamer Transcription Factor-3, Mice, Embryonic Stem Cells, SOXB1 Transcription Factors, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.